HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Cysique, Lucette A ^a,b,c   Moffat, Kirsten ^c   Moore, Danielle M ^c   Lane, Tammy A ^e   Davies, Nicholas W S ^d   Carr, Andrew ^c   Brew, Bruce J ^a,c   Rae, Caroline ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e SYDNEY EYE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CHOLINE; INOSITOL; N ACETYLASPARTIC ACID; NEOPTERIN;

ADULT; AGE; AGED; AGING; ARTICLE; BRAIN RADIOGRAPHY; BRAIN REGION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUDATE NUCLEUS; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METABOLITE; NERVOUS SYSTEM INFLAMMATION; NEUROPSYCHOLOGICAL TEST; POSTERIOR CINGULATE; PROTON NUCLEAR MAGNETIC RESONANCE; SCORING SYSTEM; WHITE MATTER;

ADULT; AFFECT; AGING; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BRAIN; BRAIN INJURIES; CARDIOVASCULAR DISEASES; COGNITION; DEMOGRAPHY; FEMALE; HIV; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROTONS; RISK FACTORS;

EID: 84876427338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061738     Document Type: Article

References (40)

1. National Centre in HIV Epidemiology and Clinical Research (2010) HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010. Sydney, NSW.
2. The Antiretroviral Therapy Cohort Collaboration, (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293-299.
3. Murray JM, McDonald AM, Law MG, (2009) Rapidly ageing HIV epidemic among men who have sex with men in Australia. Sex Health 6: 83-86.
4. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
5. Mothobi NZ, Brew BJ, (2012) Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis 25: 4-9.
6. Carr A, (2008) Pathogenesis of cardiovascular disease in HIV infection. Curr Opin HIV AIDS 3: 234-239.
7. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, et al. (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75: 864-873.
8. Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, et al. (2009) Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology 73: 1292-1299.
9. Valcour VG, Sacktor NC, Paul RH, Watters MR, Selnes OA, et al. (2006) Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. J Acquir Immune Defic Syndr 43: 405-410.
10. Holt JL, Kraft-Terry SD, Chang L, (2012) Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol 18: 291-302.
11. Becker JT, Maruca V, Kingsley LA, Sanders JM, Alger JR, et al. (2011) Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 54: 113-121.
12. Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, et al. (2010) HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis 201: 336-340.
13. Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, et al. (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 2011: 3.
14. Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, et al. (2003) A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 17: 625-633.
15. Paul RH, Ernst T, Brickman AM, Yiannoutsos CT, Tate DF, et al. (2008) Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. J Int Neuropsychol Soc 14: 725-733.
16. Gruber S, Pinker K, Riederer F, Chmelik M, Stadlbauer A, et al. (2008) Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Eur J Radiol 68: 320-327.
17. Haga KK, Khor YP, Farrall A, Wardlaw JM, (2009) A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging 30: 353-363.
18. Olson BL, Holshouser BA, Britt W, 3rd, Mueller C, Baqai W, et al (2008) Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Dis Assoc Disord 22: 269-277.
19. Haley AP, Gonzales MM, Tarumi T, Miles SC, Goudarzi K, et al. (2010) Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome. Metab Brain Dis 25: 397-405.
20. Haley AP, Tarumi T, Gonzales MM, Sugawara J, Tanaka H, (2010) Subclinical atherosclerosis is related to lower neuronal viability in middle-aged adults: a 1H MRS study. Brain Res 1344: 54-61.
21. Lane TA, Moore D, Batchelor J, Brew BJ, Cysique LA (2013) Facial emotional processing in HIV infection: relation to neurocognitive and neuropsychiatric status. Neuropsychology. In press.
22. Licata SC, Renshaw PF, (2010) Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci 1187: 148-171.
23. de Beer R, van den Boogaart A, van Ormondt D, Pijnappel WW, den Hollander JA, et al. (1992) Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 5: 171-178.
24. Kanowski M, Kaufmann J, Braun J, Bernarding J, Tempelmann C, (2004) Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. Magn Reson Med 51: 904-912.
25. Vanhamme L, van den Boogaart A, Van Huffel S, (1997) Improved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior Knowledge. J Magn Reson 129: 35-43.
26. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG, (2008) Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife- The Whitehall II study. Arterioscler Thromb Vasc Biol 28: 1556-1562.
27. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753.
28. Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, et al. (2010) Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 17: 491-501.
29. Law MG, Friis-Moller N, El-Sadr WM, Weber R, Reiss P, et al. (2006) The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med 7: 218-230.
30. Howell DC (2009) Statistical methods for Psychology. Belmont: Cengage Learning.
31. Letendre S, (2011) Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med 19: 137-142.
32. Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, et al. (2011) Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis 204: 753-760.
33. Ratai EM, Annamalai L, Burdo T, Joo CG, Bombardier JP, et al. (2011) Brain creatine elevation and N-Acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDS. Magn Reson Med 66: 625-634.
34. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, et al. (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 7: 15.
35. Cysique LA, Waters EK, Brew BJ, (2011) Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research. BMC Neurol 11: 148.
36. Raininko R, Mattsson P, (2010) Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study. Acta Radiol 51: 309-315.
37. Meyerhoff DJ, MacKay S, Bachman L, Poole N, Dillon WP, et al. (1993) Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43: 509-515.
38. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, et al. (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 55: 210-217.
39. Cui J, Forbes A, Kirby A, Simes J, Tonkin A, (2009) Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study. Eur J Cardiovasc Prev Rehabil 16: 660-668.
40. Bender R, Lange S, (2001) Adjusting for multiple testing-when and how? J Clin Epidemiol 54: 343-349.